Artelo Biosciences (ARTL) Receivables - Other (2017 - 2020)
Artelo Biosciences (ARTL) posted quarterly Receivables - Other of $29558.0 for Q1 2020, up 230.22% year-over-year from $8951.0 in Q1 2019, and down 35.16% quarter-over-quarter from $45587.0 in Q4 2019.
Artelo Biosciences (ARTL) Receivables - Other (2017 - 2020) Analysis & Trends
Artelo Biosciences (ARTL) has reported Receivables - Other for 4 consecutive years, with $29558.0 the latest figure, recorded in Q1 2020.
- In Q1 2020, Receivables - Other rose 230.22% year-over-year to $29558.0; the TTM figure through Feb 2020 stood at $29558.0 (up 230.22% YoY), while the FY2019 annual figure was -$13340.0, down 160.29% from the prior year.
- Receivables - Other slipped to $29558.0 in Q1 2020 per ARTL's latest filing, from $45587.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $45587.0 in Q4 2019 and bottomed at -$18665.0 in Q4 2018.
- Historically, Receivables - Other has averaged $12109.8 across 4 years, with a median of $8869.0 in 2019.
- Annual changes were most pronounced in 2018 — Receivables - Other slumped 2533.51% — and 2019, when it surged 1498.39%.
- Artelo Biosciences' Receivables - Other stood at $767.0 in 2017, then plunged by 2533.51% to -$18665.0 in 2018, then jumped by 344.24% to $45587.0 in 2019, then sank by 35.16% to $29558.0 in 2020.
- Business Quant data shows ARTL's Receivables - Other at $29558.0 in Q1 2020, $45587.0 in Q4 2019, and $8787.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Artelo Biosciences | 111,698.23 | -488,301.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 29, 2020 | 29,558.00 |
| Feb 29, 2020 | 29,558.00 |
| Nov 30, 2019 | 45,587.00 |
| Nov 30, 2019 | 45,587.00 |
| Aug 31, 2019 | 8,787.00 |
| Aug 31, 2019 | 8,787.00 |
| May 31, 2019 | 6,942.00 |
| May 31, 2019 | 6,942.00 |
| Feb 28, 2019 | 8,951.00 |
| Feb 28, 2019 | 8,951.00 |
| Nov 30, 2018 | -18,665.00 |
| Nov 30, 2018 | -18,665.00 |
| Aug 31, 2018 | 22,127.00 |
| Aug 31, 2018 | 22,127.00 |
| May 31, 2018 | 16,484.00 |
| May 31, 2018 | 16,484.00 |
| Feb 28, 2018 | 560.00 |
| Feb 28, 2018 | 560.00 |
| Nov 30, 2017 | 767.00 |
| Nov 30, 2017 | 767.00 |